Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antibody Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antibody Drugsmarket, defines the market attractiveness level of Antibody Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antibody Drugs industry, describes the types of Antibody Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antibody Drugs market and the development prospects and opportunities of Antibody Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antibody Drugs market in Chapter 13.
By Player:
Johnson & Johnson
Eli Lilly
F Hoffmann-La Roche
AbbVie
Novartis
Amgen
Bristol-Myers Squibb
By Type:
Monoclonal Antibodies
Antibody-Drug Conjugates
Polyclonal Antibodies
By End-User:
Central Nervous System (CNS) Disorders
Cancers
Autoimmune Disorders
Cardiovascular Diseases
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antibody Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antibody Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antibody Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antibody Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antibody Drugs Market Analysis and Outlook to 2022
-
7.1 Global Antibody Drugs Consumption (2017-2022)
-
7.2 United States Antibody Drugs Consumption (2017-2022)
-
7.3 Europe Antibody Drugs Consumption (2017-2022)
-
7.4 China Antibody Drugs Consumption (2017-2022)
-
7.5 Japan Antibody Drugs Consumption (2017-2022)
-
7.6 India Antibody Drugs Consumption (2017-2022)
-
7.7 South Korea Antibody Drugs Consumption (2017-2022)
8 Region and Country-wise Antibody Drugs Market Analysis and Outlook to 2028
-
8.1 Global Antibody Drugs Consumption Forecast (2022-2028)
-
8.2 United States Antibody Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Antibody Drugs Consumption Forecast (2022-2028)
-
8.4 China Antibody Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Antibody Drugs Consumption Forecast (2022-2028)
-
8.6 India Antibody Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Antibody Drugs Consumption Forecast (2022-2028)
9 Global Antibody Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Antibody Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Antibody-Drug Conjugates Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Polyclonal Antibodies Consumption and Growth Rate (2017-2022)
-
9.2 Global Antibody Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Central Nervous System (CNS) Disorders Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
10 Global Antibody Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Antibody Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Antibody-Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Polyclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antibody Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Central Nervous System (CNS) Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
11 Global Antibody Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antibody Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antibody Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antibody Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antibody Drugs Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson Antibody Drugs Product and Service
-
14.2 Eli Lilly
-
14.2.1 Eli Lilly Company Details
-
14.2.2 Eli Lilly Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eli Lilly Antibody Drugs Product and Service
-
14.3 F Hoffmann-La Roche
-
14.3.1 F Hoffmann-La Roche Company Details
-
14.3.2 F Hoffmann-La Roche Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 F Hoffmann-La Roche Antibody Drugs Product and Service
-
14.4 AbbVie
-
14.4.1 AbbVie Company Details
-
14.4.2 AbbVie Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 AbbVie Antibody Drugs Product and Service
-
14.5 Novartis
-
14.5.1 Novartis Company Details
-
14.5.2 Novartis Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Novartis Antibody Drugs Product and Service
-
14.6 Amgen
-
14.6.1 Amgen Company Details
-
14.6.2 Amgen Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Antibody Drugs Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Antibody Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antibody Drugs
-
Figure Antibody Drugs Picture
-
Table Global Antibody Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antibody Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antibody Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antibody Drugs Consumption by Country (2017-2022)
-
Figure United States Antibody Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Antibody Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Antibody Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Antibody Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Antibody Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antibody Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Antibody Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Antibody Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antibody Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antibody Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antibody Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antibody Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antibody Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Antibody-Drug Conjugates Consumption and Growth Rate (2017-2022)
-
Figure Global Polyclonal Antibodies Consumption and Growth Rate (2017-2022)
-
Figure Global Central Nervous System (CNS) Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Cancers Consumption and Growth Rate (2017-2022)
-
Figure Global Autoimmune Disorders Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antibody-Drug Conjugates Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Polyclonal Antibodies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Central Nervous System (CNS) Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Autoimmune Disorders Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antibody Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antibody Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Antibody Drugs Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Antibody Drugs Product and Service
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Antibody Drugs Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Antibody Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Antibody Drugs Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Antibody Drugs Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Antibody Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Antibody Drugs Product and Service
-
